Hyperbilirubinemia transient familial neonatal

Transient Familial Neonatal Hyperbilirubinemia (TFNH) is a rare genetic disorder characterized by elevated levels of bilirubin in the blood of newborns. This condition typically manifests in the first week of life and is distinguished by its transient nature, with symptoms usually resolving within one to two weeks. The disorder is familial, indicating a genetic predisposition, and is more common in certain populations due to genetic factors.

Causes

TFNH is caused by mutations in specific genes involved in the metabolism and clearance of bilirubin from the body. Bilirubin is a yellow compound that occurs in the blood as a byproduct of the breakdown of red blood cells. Normally, the liver processes bilirubin, which is then excreted from the body. In TFNH, genetic mutations impair the liver's ability to process and excrete bilirubin efficiently, leading to hyperbilirubinemia.

Symptoms

The primary symptom of TFNH is jaundice, which is characterized by a yellowing of the skin and the whites of the eyes. This is due to the accumulation of bilirubin in the blood. Other symptoms may include lethargy, poor feeding, and in severe cases, the risk of kernicterus, a form of brain damage caused by very high levels of bilirubin.

Diagnosis

Diagnosis of TFNH involves a combination of clinical observation, family history, and laboratory tests. Blood tests are used to measure the levels of bilirubin in the newborn's blood. Genetic testing may also be conducted to identify specific mutations associated with the condition.

Treatment

Treatment for TFNH is primarily supportive and aims to reduce bilirubin levels in the blood. This may include phototherapy, where the baby is exposed to a type of light that helps break down bilirubin in the skin. In more severe cases, exchange transfusion may be necessary. This procedure involves slowly removing the baby's blood and replacing it with fresh donor blood or plasma to rapidly decrease bilirubin levels.

Prognosis

The prognosis for infants with TFNH is generally excellent, as the condition is transient and typically resolves on its own within one to two weeks. With appropriate treatment, long-term complications are rare. However, monitoring is essential to prevent the risk of kernicterus.

Epidemiology

The exact prevalence of TFNH is unknown, but it is considered a rare condition. It has a familial pattern of inheritance, suggesting a genetic component to its occurrence.

Hyperbilirubinemia transient familial neonatal Resources
Latest articles Most recent articles Ongoing trials	Wikipedia